Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
Inovio Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: March 28, 2023
Inovio Pharmaceuticals reported fiscal year 2022 executive compensation information on March 28, 2023.
In 2022, four executives at Inovio Pharmaceuticals received on average a compensation package of $4.3M, a 31% increase compared to previous year.
Average pay of disclosed executives at Inovio Pharmaceuticals
J. Joseph Kim, Chief Executive Officer, received $10M in total, which increased by 68% compared to 2021. 41% of Kim's compensation, or $4.3M, was in option awards. Kim also received $524K in salary, $3M in stock awards, as well as $2.7M in other compensation.
Jacqueline E. Shea, Chief Executive Officer, received a compensation package of $3.5M, which increased by 52% compared to previous year. 36% of the compensation package, or $1.3M, was in option awards.
Peter D. Kies, Chief Financial Officer, earned $1.6M in 2022, a 30% decrease compared to previous year.
Laurent M. Humeau, Chief Scientific Officer, received $1.6M in 2022, which decreases by 31% compared to 2021.
Related executives
You may also like
Source: SEC filing on March 28, 2023.